| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Furosemide measurement |
Component |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Furosemide poisoning |
Causative agent (attribute) |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Accidental frusemide poisoning |
Causative agent (attribute) |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Intentional frusemide poisoning |
Causative agent (attribute) |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Frusemide poisoning of undetermined intent |
Causative agent (attribute) |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Frusemide adverse reaction (disorder) |
Causative agent (attribute) |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Allergy to furosemide |
Causative agent (attribute) |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Frusemide overdose (disorder) |
Causative agent (attribute) |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Accidental frusemide overdose |
Causative agent (attribute) |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Intentional furosemide overdose |
Causative agent (attribute) |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Frusemide overdose of undetermined intent |
Causative agent (attribute) |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Furosemide 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| frusémide 10 mg/mL, seringue préremplie de 8 mL pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Frusemide 20mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Frusemide 40mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Frusemide 50mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| frusémide 10 mg/mL, ampoule de 5 mL pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Furosemide 1 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| furosémide 10 mg/mL, ampoule de 2 mL pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| frusémide 10 mg/mL, fiole de 25 mL pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Product containing furosemide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Product containing furosemide in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Furosemide 10mg/mL injection solution 2ml ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Furosemide 40mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Furosemide 20mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Furosemide 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Product containing furosemide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Furosemide 20 mg and spironolactone 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Amiloride hydrochloride 5 mg and furosemide 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Amiloride hydrochloride 10 mg and furosemide 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Frusemide+potassium 40mg/8Mmol m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Frusemide+potassium 20mg/10Mmol m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Co-amilofruse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Co-amilofruse tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Product containing furosemide and spironolactone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
| Product containing furosemide and potassium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Product containing furosemide and triamterene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
| Furosemide 10mg/mL injection solution 4mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Furosemide 10mg/mL injection solution 10mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Product containing precisely furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Product containing precisely furosemide 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| furosémide 10 mg/mL, ampoule de 2 mL pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Accidental frusemide poisoning |
Causative agent (attribute) |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
| Intentional frusemide poisoning |
Causative agent (attribute) |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
| Product containing furosemide and potassium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Allergy to furosemide |
Causative agent (attribute) |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Product containing amiloride and furosemide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Amiloride hydrochloride 5 mg and furosemide 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
| Amiloride hydrochloride 5 mg and furosemide 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
| Amiloride hydrochloride 10 mg and furosemide 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Amiloride hydrochloride 10 mg and furosemide 80 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Furosemide 20 mg and spironolactone 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
| Furosemide 20 mg and spironolactone 50 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely furosemide 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely furosemide 40 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Furosemide 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Furosemide 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Furosemide 20 mg and spironolactone 50 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Amiloride hydrochloride 10 mg and furosemide 80 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
| Furosemide 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Furosemide 80 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
| Amiloride hydrochloride 5 mg and furosemide 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Frusemide+potassium 40mg/8Mmol prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Frusemide+potassium 20mg/10Mmol prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
| Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
| Amiloride hydrochloride 10 mg and furosemide 80 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
| Furosemide 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Furosemide 80 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Amiloride- and furosemide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely furosemide 40 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
| Furosemide 20 mg and spironolactone 50 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Amiloride hydrochloride 5 mg and furosemide 40 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Product containing furosemide and triamterene in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely furosemide 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely furosemide 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Furosemide 4 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Furosemide 4 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely furosemide 8 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely furosemide 8 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Furosemide 1 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Furosemide 1 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely furosemide 20 milligram/2 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely furosemide 20 milligram/2 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely furosemide 50 milligram/5 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely furosemide 50 milligram/5 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely furosemide 80 milligram/8 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely furosemide 80 milligram/8 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
| Product containing furosemide and spironolactone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
| Product containing only amiloride and furosemide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]